Skip to content

Screening TO Prevent ColoRectal Cancer (STOP CRC) Among At-Risk Chinese and Korean American Primary Care Patients

Culturally Adapted Multilevel Decision Support Navigation Trial To Reduce Colorectal Cancer Disparity Among At-Risk Asian American Primary Care Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03481296
Enrollment
400
Registered
2018-03-29
Start date
2018-08-20
Completion date
2021-06-30
Last updated
2023-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Keywords

Colorectal Cancer Screening, Asian Americans, Patient Navigation, Decision Counseling Program

Brief summary

The objective of the study is to conduct a randomized controlled trial to determine the impact of a multi-level culturally-sensitive decision support intervention on colorectal cancer screening adherence among 400 Chinese and Korean American primary care patients.

Detailed description

This study culturally adapts existing evidence-based decision support navigation intervention and tests its efficacy among 200 Chinese and Korean American men and 200 Chinese and Korean American women aged 50 to 75 eligible for colorectal cancer screening. Participants are recruited from primary care physician clinics. The study is designed to compare colorectal cancer screening outcomes between the decision support navigation intervention and the advanced control. Those randomized to the advanced control group only receives an informational booklet, a stool blood test kit and a reminder by mail. Those randomized to the decision support navigation intervention group receives everything the advanced control group receives as well as decision support and navigation contacts. Investigators in the study develop an individualized screening plan using a theory-based online Decision Counseling Program, share the plan with the participants' primary care physicians, and have primary care physicians to encourage the colorectal cancer screening to participants. Using outcomes data collected by survey and medical record review, this study: (1) determines overall colorectal cancer screening adherence in the culturally adapted decision support navigation intervention vs. the advanced control; (2) measures change in colorectal cancer screening decision stage in the culturally adapted decision support navigation intervention vs. the advanced control; and (3) assesses colorectal cancer screening test-specific (stool blood test vs. colonoscopy) adherence in the culturally adapted decision support navigation intervention vs. the advanced control. Additionally, investigators in the study evaluate intervention reach, effectiveness, adoption, implementation, and maintenance using interview data.

Interventions

BEHAVIORALAdvanced Control

Participants receive linguistically and culturally tailored information booklet on colorectal cancer and colorectal cancer screening, colonoscopy instructions, stool blood test kits and reminder by mail. Participants' height, weight, and waist/hip circumference, blood pressure, blood glucose, and cholesterol levels will be measured by trained research staff. Participants will also receive the result of body measurements right away as a free service.

BEHAVIORALCulturally-Adapted Decision Support Navigation Intervention

Participants in this group receive everything that advanced control group receives. In addition to a set of standard materials, they receive culturally and linguistically adapted decision counseling from the patient navigator. The patient navigator develops an individualized colorectal cancer screening plan using a theory-based online Decision Counseling Program. After the Program is completed, the patient navigator develops individualized colorectal cancer screening plan and shares the information with participants and participants' primary care physicians. Then, primary care physicians encourage the colorectal cancer screening to participants.

Sponsors

National Institute on Minority Health and Health Disparities (NIMHD)
CollaboratorNIH
Thomas Jefferson University
CollaboratorOTHER
University of Maryland, College Park
CollaboratorOTHER
University of California, Irvine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
50 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Male and female Chinese and Korean American patients aged 50 to 75, who are not up to date for colorectal cancer screening

Exclusion criteria

* Those with a family history, previous history of removing polyps, inflammatory bowel disease, or diagnosis of colorectal cancer screening.

Design outcomes

Primary

MeasureTime frameDescription
Colorectal cancer screening test-specific adherence at 12 months (Stool Blood Test)12 monthsMeasure the fraction of participants who undergo a stool blood test at 12 months.
Change in colorectal cancer screening decision stage between baseline and 6 months (Colonoscopy)Baseline and 6 monthsMeasure change in colorectal cancer screening decision stage for colonoscopy between baseline and 6 months.
Colorectal cancer screening test-specific adherence at 6 months (Stool Blood Test)6 monthsMeasure the fraction of participants who undergo a stool blood test at 6 months.
Colorectal cancer screening test-specific adherence at 6 months (Colonoscopy)6 monthsMeasure the fraction of participants who undergo a colonoscopy at 6 months.
Colorectal cancer screening test-specific adherence at 12 months (Colonoscopy)12 monthsMeasure the fraction of participants who undergo a colonoscopy at 12 months.
Colorectal cancer screening adherence at 6 months by medical record review6 monthsMeasure overall colorectal cancer screening adherence at 6 months by medical record review.
Colorectal cancer screening adherence at 6 months by self-report6 monthsMeasure overall colorectal cancer screening adherence at 6 months by self-report during 6-month survey (by phone).
Overall colorectal cancer screening adherence at 12 months by medical record review12 monthsMeasure overall colorectal cancer screening adherence at 12 months by medical record review.
Overall colorectal cancer screening adherence at 12 months by self-report12 monthsMeasure overall colorectal cancer screening adherence at 12 months by self-report (by phone interview).
Colorectal cancer screening decision stage at baseline (Stool Blood Test)BaselineMeasure colorectal cancer screening decision stage for stool blood test at baseline.
Colorectal cancer screening decision stage at 6-months (Stool Blood Test)6 monthsMeasure colorectal cancer screening decision stage for stool blood test at 6 months.
Change in colorectal cancer screening decision stage between baseline and 6 months (Stool Blood Test)Baseline and 6 monthsMeasure change in colorectal cancer screening decision stage for stool blood test between baseline and 6 months.
Colorectal cancer screening decision stage at baseline (Colonoscopy)BaselineMeasure colorectal cancer screening decision stage for colonoscopy at baseline.
Colorectal cancer screening decision stage at 6 months (Colonoscopy)6 monthsMeasure colorectal cancer screening decision stage for colonoscopy at 6 months.

Secondary

MeasureTime frameDescription
Knowledge about colorectal cancer and colorectal cancer screening (6 months)6 monthsMeasure knowledge about colorectal cancer and colorectal cancer screening at 6 months.
Change in knowledge about colorectal cancer and colorectal cancer screening between baseline and 6 monthsBaseline and 6 monthsMeasure change in knowledge score about colorectal cancer and colorectal cancer screening between baseline and 6 months.
Knowledge about colorectal cancer and colorectal cancer screening (Baseline)BaselineMeasure knowledge about colorectal cancer and colorectal cancer screening at baseline.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026